Late radiation necrosis following stereotactic radiosurgery after COVID-19 vaccination: a case report and hypothesis of immune-mediated inflammatory activation - Scorecard - MDSpire
Advertisement
Late radiation necrosis following stereotactic radiosurgery after COVID-19 vaccination: a case report and hypothesis of immune-mediated inflammatory activation
Clinical Scorecard: Delayed Radiation Necrosis After Stereotactic Radiosurgery in a Patient Vaccinated for COVID-19: A Case Study and Exploration of Immune-Related Inflammatory Response
At a Glance
Category
Detail
Condition
Radiation Necrosis
Key Mechanisms
Systemic immune activation and chronic inflammatory response in irradiated CNS tissue.
Target Population
Patients with brain metastases treated with stereotactic radiosurgery.
Care Setting
Oncology and neurology clinical settings.
Key Highlights
Radiation necrosis can occur 46 months post-stereotactic radiosurgery.
Advanced imaging may not reliably distinguish between radiation necrosis and recurrent tumors.
Systemic immune activation, including from COVID-19 vaccinations, may contribute to delayed radiation necrosis.
Guideline-Based Recommendations
Diagnosis
Consider advanced imaging modalities, but be aware of their limitations in specificity.
Management
Monitor for delayed radiation necrosis in patients with prior stereotactic radiosurgery.
Monitoring & Follow-up
Regular surveillance MRIs to assess for new lesions or changes in previously treated areas.
Risks
Increased risk of radiation necrosis with systemic immune stimulation and immunotherapy.
Patient & Prescribing Data
Patients with metastatic non-small cell lung cancer and brain metastases.
Combination of stereotactic radiosurgery and immunotherapy may complicate the clinical picture.
Clinical Best Practices
Maintain a high index of suspicion for delayed radiation necrosis in long-term survivors post-SRS.
Integrate multidisciplinary approaches for diagnosis and management of suspected radiation necrosis.
